Fuso Chemical (TSE:4368) Stock Price Meets Q2 Results With Valuation Reset

Fuso Chemical came into this Q2 2027 print with a rich valuation and a reputation for steady compounding, yet the stock closed at ¥2,889 on 30 October after a choppy few months. On the headline numbers, the story is less jittery than the chart. Quarterly net income reached ¥4,974m on revenue of ¥22,777m, keeping trailing earnings power solid and margins healthy. The real friction point is that this quality is already priced in, with the P/E sitting above sector and peer averages. This leaves today’s muted share move feeling more like a valuation check rather than a verdict on the business.

Love Fuso ChemicalLtd's healthy earnings and margin profile but worried that the premium P/E already reflects much of that quality? Consider using our screener of high quality companies on more forgiving valuations and benchmark it against 16 high quality undervalued stocks.

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs. Q2 2026): ¥22,777m vs. ¥19,046.9m (up about 19.6%)
• Net Income (Q2 2027 vs. Q2 2026): ¥4,974m vs. ¥3,773.8m (up about 31.8%)
• Basic EPS (Q2 2027 vs. Q2 2026): ¥47.01 vs. ¥35.67 (up about 31.7%)
• Trailing 12-Month Net Income (Q2 2027 TTM vs. Q2 2026 TTM): ¥19,094m vs. ¥12,893m (up about 48.1%)

If you are finding it difficult to sift through detailed earnings reports and raw figures for Fuso ChemicalLtd, you can view the full financial picture in a clear visual format, including a straightforward valuation breakdown, through our company report for Fuso ChemicalLtd.

Fuso Chemical’s results keep the quality story alive

For anyone leaning optimistic on Fuso Chemical, these figures give that view some footing. Revenue of ¥22,777m and quarterly net income of ¥4,974m both exceed the prior year, and earnings per share also move in the same direction. Trailing 12 month profit of ¥19,094m sits comfortably above the prior period. That pattern fits a specialty producer that keeps finding demand across food additives, cosmetics and electronic materials. The message is simple: the business model still converts sales into healthy earnings.

Short term share performance flags valuation questions

Bears have a different angle. The stock has fallen about 23% over 90 days and about 14% over 30 days, even as profits and revenue step higher. That gap between solid reported performance and weaker price action often points less to operational strain and more to investor concerns about how much was already baked into expectations. On this set of numbers, immediate pressure looks more about what investors are willing to pay than about any clear deterioration in Fuso Chemical’s financial footing.

Are analysts backing the idea that Fuso Chemical has strong operations but a stretched valuation, or leaning the other way? Check the consensus price target analysis for Fuso ChemicalLtd.

Hunt For The Next Disconnect

Fuso ChemicalLtd shows how firm earnings power and a bumpy share price can pull in different directions. The real opportunity is finding stocks that could be undervalued before the market corrects them.

• Company 1 - 33% below our estimate - supplies high precision photomasks that chipmakers adopt for more complex next generation process designs.
• Company 2 - 45% below our estimate - serves depositors and borrowers shifting to a single banking group offering integrated lending, leasing and securities products.
• Company 3 - 37% below our estimate - wins air and water systems work as data centres and nuclear facilities upgrade temperature and safety requirements.

That is three of the list. See all 16 potentially undervalued companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com